Amalgamated Bank’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,584	Closed	-$196K	–	2778
2025 Q4	$196K	Sell	5,584 -220	-4%	-$7.79K	﹤0.01%	1572
2025 Q3	$153K	Buy	5,804 +60	+1%	+$1.79K	﹤0.01%	1634
2025 Q2	$152K	Sell	5,744 -1,521	-21%	-$40K	﹤0.01%	1620
2025 Q1	$175K	Buy	7,265 +265	+4%	+$8.38K	﹤0.01%	1560
2024 Q4	$282K	Hold	7,000	–	–	﹤0.01%	1484
2024 Q3	$443K	Sell	7,000 -35	-0.5%	-$2.05K	﹤0.01%	1344
2024 Q2	$373K	Buy	7,035 +3,578	+104%	+$235K	﹤0.01%	1407
2024 Q1	$283K	Sell	3,457 -10,156	-75%	-$452K	﹤0.01%	1501
2023 Q4	$253K	Sell	13,613 -965	-7%	-$12.6K	﹤0.01%	1722
2023 Q3	$161K	Hold	14,578	–	–	﹤0.01%	1853
2023 Q2	$236K	Buy	+14,578	New	+$305K	﹤0.01%	1761
2022 Q2	–	Sell	-8,272	Closed	-$25K	–	3209
2022 Q1	$25K	Buy	+8,272	New	+$29.7K	﹤0.01%	2737
2020 Q2	–	Sell	-10,082	Closed	-$47K	–	1654
2020 Q1	$47K	Sell	10,082 -380	-4%	-$2.34K	﹤0.01%	1577
2019 Q4	$84K	Buy	+10,462	New	+$76.3K	﹤0.01%	1751